Clinical Trial Update: Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of bortezomib and lenalidomide (Revlimid) for patients with multiple myeloma who relapsed or progressed on Total Ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED